serevent news
Contact Information

Greg Monforton and Partners

100 Ouellette Avenue
13th Floor
Windsor, Ontario N9A 6T3

519-258-6490
800-663-1145

serevent lawsuit news
Serevent News

Greg Monforton and Partners provides the latest news on the Serevent side effects warning and details on Serevent lawsuits.

Most of the news stories below require Adobe Acrobat to view.

Common Asthma Inhalers Cause up to 80 Percent of Asthma-Related Deaths, Cornell and Stanford Researchers Asserts
Chronicle Online | June 9, 2006

Three common asthma inhalers containing the drugs salmeterol or formoterol may be causing four out of five U.S. asthma-related deaths per year and should be taken off the market, researchers from Cornell and Stanford universities have concluded after a search of medical literature.

They base these conclusions on a statistical analysis of 19 published trials involving 33,826 patients. This so-called meta-analysis found that patients who inhaled the long-acting beta-agonists salmeterol (trade names Serevent and Advair, both made by GlaxoSmithKline) or formoterol (trade name Foradil, made by Novartis Pharmaceuticals) were 3.5 times more likely to die from asthma and 2.5 times more likely to be hospitalized (whether or not death resulted), compared with those taking a placebo.

Study Fuels Debate Over Beta Agonists Such as Serevent and Advair
CBC News | June 8, 2006

Adding to the ongoing controversy over a popular class of asthma inhaler medications, a new data review suggests the drugs may be dangerous.

Compared to placebo, the "long-acting beta-agonist bronchodilator" inhalers (which include Serevent and Advair) more than triped users' risk of asthma-linked death, according to the report. Risks of hospitalization and life-threatening complications also went up.

FDA Adds Warnings to Serevent, Advair
MSNBC | August 9, 2004

GlaxoSmithKline PLC's asthma drugs Serevent and Advair will carry new warnings about a small risk of life-threatening asthma episodes or asthma-related deaths, the Food and Drug Administration said Thursday.

MedWatch—Serevent "Dear Healthcare Professional" Letter
GlaxoSmithKline/FDA

GlaxoSmithKline is writing to you, as a prescriber of Serevent® (salmeterol xinafoate), to communicate important safety information, and reinforce and reiterate advice on the appropriate prescribing of Serevent in patients with asthma.

Serevent Lawsuit

Greg Monforton and Partners is handling legal claims on behalf of those injured by Serevent.

If you or a loved one has been injured by Serevent, we invite you to contact us for a free, confidential consultation about your legal rights. We will represent clients throughout Canada in lawsuits against GlaxoSmithKline, the manufacturer of Serevent.

For more news about the Serevent lawsuit, please complete our online form.

Contact Form
Name
Phone
Email
 

About Us

Greg Monforton and Partners has grown to a highly respected products liability law firm with offices conveniently located throughout Windsor and Essex County, together with affiliate relationships with law firms throughout Ontario, Canada and the United States.

We are committed to protecting the rights of individuals injured by dangerous pharmaceuticals. The firm never represents insurance companies or product manufacturers. We only help people.